niceritrol has been researched along with Arteriosclerosis in 14 studies
Niceritrol: An ester of nicotinic acid that lowers cholesterol and triglycerides in total plasma and in the VLD- and LD-lipoprotein fractions.
Arteriosclerosis: Thickening and loss of elasticity of the walls of ARTERIES of all sizes. There are many forms classified by the types of lesions and arteries involved, such as ATHEROSCLEROSIS with fatty lesions in the ARTERIAL INTIMA of medium and large muscular arteries.
| Excerpt | Relevance | Reference |
|---|---|---|
| "On treatment with niceritrol, the cholesterol level was reduced most in the very low density lipoprotein (VLDL) fraction (d less than 1." | 1.27 | Effect of niceritrol on lipid metabolism of aorta in atherosclerotic rats. ( Ishikawa, Y; Matsuoka, N; Murano, S; Nishide, T; Saito, Y; Sasaki, N; Sato, A; Shirai, K; Yoshida, S, 1984) |
| "Prophylactic treatment of the hyperlipoproteinemia with the drugs niceritrol (Perycit) and beta-pyridylcarbinol (Ronicol) significantly reduced the elevated plasma cholesterol level and reduced the degree of atherosclerosis in the abdominal aorta and the coronary arteries." | 1.27 | [Experimental hyperlipoproteinemia and arteriosclerosis in minipigs--effect of various drugs]. ( Jacobsson, L, 1986) |
| "Niceritrol treatment was associated with increased blood glucose, decreased K value, elevated fasting serum insulin and serum insulin at 60 min during IVGTT." | 1.26 | Changes in glucose tolerance and plasma insulin during lipid-lowering treatment with diet, clofibrate and niceritrol. ( Hellsing, K; Lithell, H; Vessby, B, 1982) |
| "Niceritrol treatment significantly reduced the Chol/TG ratio in VLDL while no such effect was seen during clofibrate administration." | 1.26 | Pronounced lipoprotein lipid reduction obtained by combined lipid-lowering treatment in patients with atherosclerotic disease. ( Borberg, J; Gustafsson, IB; Lithell, H; Vessby, B, 1979) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 8 (57.14) | 18.7374 |
| 1990's | 5 (35.71) | 18.2507 |
| 2000's | 1 (7.14) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fujioka, T | 1 |
| Ueno, T | 1 |
| Matsumoto, T | 1 |
| Watanabe, H | 1 |
| Shirai, K | 1 |
| Ishikawa, Y | 1 |
| Nishide, T | 1 |
| Sasaki, N | 1 |
| Murano, S | 1 |
| Sato, A | 1 |
| Matsuoka, N | 1 |
| Saito, Y | 1 |
| Yoshida, S | 1 |
| Lithell, H | 2 |
| Vessby, B | 2 |
| Hellsing, K | 1 |
| Numata, M | 1 |
| Takahashi, S | 1 |
| Yamamoto, T | 1 |
| Moriwaki, Y | 1 |
| Tsutsumi, Z | 1 |
| Higashino, K | 1 |
| Spinler, SA | 1 |
| Cziraky, MJ | 1 |
| Murase, T | 1 |
| Saika, Y | 1 |
| Kodama, N | 1 |
| Kimura, K | 1 |
| Fujii, R | 1 |
| Ohtani, H | 1 |
| Mune, M | 1 |
| Mimura, K | 2 |
| Maeda, T | 1 |
| Yukawa, S | 2 |
| Gustafsson, IB | 1 |
| Borberg, J | 1 |
| Lundholm, L | 1 |
| Jacobsson, L | 2 |
| Brattsand, R | 1 |
| Magnusson, O | 1 |
| Hamazaki, T | 1 |
| Hasunuma, K | 1 |
| Kobayashi, S | 1 |
| Shishido, H | 1 |
| Yano, S | 1 |
| Nagakawa, Y | 1 |
| Orimo, H | 1 |
| Harasawa, M | 1 |
3 reviews available for niceritrol and Arteriosclerosis
| Article | Year |
|---|---|
[Dyslipidemia in renal failure].
Topics: Arteriosclerosis; Cerebrovascular Disorders; Cholesterol, HDL; Cholesterol, LDL; Clofibrate; Coronar | 2004 |
Lipoprotein(A): physiologic function, association with atherosclerosis, and effects of lipid-lowering drug therapy.
Topics: Animals; Anticholesteremic Agents; Arteriosclerosis; Clinical Trials as Topic; Humans; Hydroxymethyl | 1994 |
[High Lp (a) concentrations].
Topics: Arteriosclerosis; Blood Component Removal; Coronary Artery Disease; Humans; Hyperlipoproteinemias; H | 1998 |
11 other studies available for niceritrol and Arteriosclerosis
| Article | Year |
|---|---|
Effect of niceritrol on lipid metabolism of aorta in atherosclerotic rats.
Topics: Adipose Tissue; Animals; Aorta; Arteriosclerosis; Diet, Atherogenic; Lipid Metabolism; Lipids; Lipop | 1984 |
Changes in glucose tolerance and plasma insulin during lipid-lowering treatment with diet, clofibrate and niceritrol.
Topics: Aged; Arteriosclerosis; Blood Glucose; Body Weight; Clofibrate; Dietary Carbohydrates; Female; Gluco | 1982 |
Contributions of vasoactive substances in cases of chronic arteriosclerotic occlusion in the lower extremities.
Topics: Aged; Arteriosclerosis; Humans; Leg; Lipids; Middle Aged; Niceritrol; Nicotine; Nicotinic Acids; Nor | 1982 |
Increased concentrations of serum Lp(a) lipoprotein in patients with primary gout.
Topics: Adult; Aged; Aged, 80 and over; Apolipoproteins B; Arteriosclerosis; Cholesterol, HDL; Enzyme-Linked | 1995 |
[Plasma nicotinic acid levels in hemodialysis patients after the administration of niceritrol].
Topics: Arteriosclerosis; Humans; Hypolipidemic Agents; Kidney Failure, Chronic; Lipoprotein(a); Niacin; Nic | 1999 |
Pronounced lipoprotein lipid reduction obtained by combined lipid-lowering treatment in patients with atherosclerotic disease.
Topics: Adult; Aged; Arteriosclerosis; Clofibrate; Female; Humans; Hyperlipoproteinemia Type II; Hyperlipopr | 1979 |
Influence of nicotinic acid, niceritrol and beta-pyridylcarbinol on experimental hyperlipidemia and atherosclerosis in mini-pigs.
Topics: Animals; Aorta; Arteriosclerosis; Cholesterol; Coronary Vessels; Humans; Hyperlipidemias; Lipoprotei | 1978 |
[Hyperlipidemia and drug treatment].
Topics: Arteriosclerosis; Carnitine; Cholestyramine Resin; Glomerulonephritis; Humans; Hyperlipidemias; Kidn | 1991 |
[Experimental hyperlipoproteinemia and arteriosclerosis in minipigs--effect of various drugs].
Topics: Animals; Arteries; Arteriosclerosis; Cholesterol; Hypercholesterolemia; Hyperlipoproteinemias; Hypol | 1986 |
The effects on lipids, blood viscosity and platelet aggregation of combined use of niceritrol (Perycit) and a low dose of acetylsalicylic acid.
Topics: Adult; Aged; Arteriosclerosis; Aspirin; Blood Viscosity; Diabetes Mellitus; Female; Fibrinogen; Huma | 1985 |
The anti-platelet effect of niceritrol in patients with arteriosclerosis and the relationship of the lipid-lowering effect to the anti-platelet effect.
Topics: Adenosine Diphosphate; Adult; Aged; Arteriosclerosis; Blood Platelets; Cholesterol; Collagen; Female | 1985 |